Form D — Persevere Therapeutics Inc.
0002115419-26-000001 · filed 2026-03-04
Offering
- Industry
- Other
- Exemptions
- 06b
- Total offering
- $4,999,999
- Total sold
- $1,574,999
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Persevere Therapeutics Inc.
- CIK
- 2115419
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2025
- Address
- 851 DUPORTAIL ROAD, 2ND FLOOR
CHESTERBROOK, PA 19087 - Phone
- 610.780.0622
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Greg Bosch · Executive OfficerCHESTERBROOK, PA Find on LinkedIn ↗
View original on SEC EDGAR.